Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Calibration Curves: Linear Least Squares01:20

Calibration Curves: Linear Least Squares

2.9K
A calibration curve is a plot of the instrument's response against a series of known concentrations of a substance. This curve is used to set the instrument response levels, using the substance and its concentrations as standards. Alternatively, or additionally, an equation is fitted to the calibration curve plot and subsequently used to calculate the unknown concentrations of other samples reliably.
For data that follow a straight line, the standard method for fitting is the linear...
2.9K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

783
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
783
Censoring Survival Data01:09

Censoring Survival Data

270
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
270
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

4.3K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
4.3K
Prediction Intervals01:03

Prediction Intervals

2.4K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
2.4K
The Anchoring-and-Adjustment Heuristic01:25

The Anchoring-and-Adjustment Heuristic

7.5K
In order to make good decisions, we use our knowledge and our reasoning. Often, this knowledge and reasoning is sound and solid. However, sometimes, we are swayed by biases or by others manipulating a situation. For example, let’s say you and three friends wanted to rent a house and had a combined target budget of $1,600. The realtor shows you only very run-down houses for $1,600 and then shows you a very nice house for $2,000. Might you ask each person to pay more in rent to get the...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CT Perfusion Blood Flow Provides an Early Response Marker for Progression-free Survival in a Prospective Randomized Clinical Trial of Metastatic Renal Cell Carcinoma.

Technology in cancer research & treatment·2026
Same author

Special issue: cell and gene causal inference in the design and analysis of gene therapy clinical trials.

Journal of biopharmaceutical statistics·2026
Same author

Pretreatment Risk Model for Radiation-Induced Lymphopenia Is Associated With Adjuvant Durvalumab Efficacy in Patients With Unresectable Stage III NSCLC.

International journal of radiation oncology, biology, physics·2026
Same author

Examining covariate-specific treatment effects in individual participant data meta-analysis: Framing aggregation bias in terms of trial-level confounding and funnel plots.

Research synthesis methods·2026
Same author

PD-L1 subpopulations of metastatic urothelial carcinoma demonstrate heterogeneity to chemotherapy: an integrated analysis of digitized trial results.

Cancer metastasis reviews·2026
Same author

Aligning cardiac monitoring with American Heart Association Guidelines: Impact on utilization, hemodynamic monitoring, and outcomes.

PloS one·2026
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Oct 4, 2025

Measuring Delay Discounting in Humans Using an Adjusting Amount Task
07:47

Measuring Delay Discounting in Humans Using an Adjusting Amount Task

Published on: January 9, 2016

15.6K

Calibrated dynamic borrowing using capping priors.

Sharon X Ling1, Brian P Hobbs2, Alexander M Kaizer3

  • 1Division of Biostatistics, School of Public Health, University of Minnesota, United States.

Journal of Biopharmaceutical Statistics
|February 7, 2022
PubMed
Summary
This summary is machine-generated.

Multisource exchangeability models (MEMs) improve clinical trial efficiency. We introduce "capping priors" to prevent large supplementary trials from overwhelming primary trial data, ensuring balanced information integration.

Keywords:
Multisource exchangeability modelscapping priorsprior specificationreduced nicotine content cigarettessupplementary data

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.4K

Related Experiment Videos

Last Updated: Oct 4, 2025

Measuring Delay Discounting in Humans Using an Adjusting Amount Task
07:47

Measuring Delay Discounting in Humans Using an Adjusting Amount Task

Published on: January 9, 2016

15.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.4K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Bayesian Inference

Background:

  • Multisource exchangeability models (MEMs) offer a Bayesian approach to enhance randomized controlled trial (RCT) efficiency by integrating data from multiple sources.
  • Integrating supplementary trial data, especially when significantly larger than the primary trial, requires careful management to prevent bias.

Purpose of the Study:

  • To propose a novel Bayesian method, "capping priors," to control information borrowing in MEMs.
  • To ensure that large supplementary datasets do not disproportionately influence primary trial results.

Main Methods:

  • Development of the "capping priors" technique, which imposes an a priori limit on the effective sample size of supplementary data.
  • Simulation studies to evaluate the performance and behavior of the capping priors method.
  • Application of the method to real-world data from four clinical trials involving very low nicotine content cigarettes.

Main Results:

  • The capping priors method effectively regulates the influence of supplementary data in MEMs.
  • Demonstrated control over the degree of information borrowing, preventing the primary trial from being overwhelmed.
  • Successful application in a practical setting, showcasing its utility in nicotine cigarette trials.

Conclusions:

  • Capping priors provide a robust mechanism for dynamic data integration in clinical trials.
  • This method enhances the efficiency and reliability of multisource exchangeability models, particularly when dealing with heterogeneous trial sizes.
  • The approach is validated for use in complex clinical trial scenarios, such as those evaluating smoking cessation interventions.